Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NENT Group to launch ‘Kin’ as its next Viaplay Original

· Star-studded cast with Charlie Cox (‘Boardwalk Empire’), Clare Dunne (‘Herself’) and Aidan Gillen (‘Game of Thrones’) in leading roles · ‘Kin’ is produced by BRON Studios and Headline Pictures · NENT Group to premiere at least 40 original productions in 2021 Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company will premiere drama series ‘Kin’ as its next Viaplay Original. The eight episode long series sees Charlie Cox (‘Boardwalk Empire’), Clare Dunne (‘Herself’) and BAFTA nominated actor Aidan Gillen (‘Game of Thrones’) in the leading roles and

Payment of share rewards based on the share-based incentive programme as a directed share issue of own shares of the company without consideration

Pihlajalinna Plc                   Stock Exchange Release     19 February 2021 at 9.30 a.m. Payment of share rewards based on the share-based incentive programme as a directed share issue of own shares of the company without consideration On 19 February 2021, the Board of Directors of Pihlajalinna Plc has confirmed the maximum number of performance-based additional shares, 56,583 shares, earned based on the earning period 2020 of the share-based incentive programme which commenced in 2019 for the company's key personnel and resolved on the payment of the share rewards earned based on

Eurocine Vaccines publishes half-year report for July-December 2020

Eurocine Vaccines AB (“Eurocine Vaccines”) hereby publishes an interim report for the first half year of 2020. Below is a summary of the report. The full report is available on the Euroccine Vaccines website and as an attachment.2020-07-01– 2020-12-31 (first half year) · Result after tax during the first half year amounted to -7,6 MSEK (-4,7 MSEK) · Revenues during the half year amounted to 0,4 MSEK (0 MSEK) · Earnings per share the half year -0,01 SEK (-0,03 SEK) CEO Hans Arwidsson comments “It has been an incredibly exciting period for

Crunchfish enrolled to VISA Technology Partner program

Crunchfish AB (“Crunchfish”) announces its enrolment into VISA Technology Partner program with its Digital Cash solutions. As a VISA technology partner, Crunchfish will get access to VISA specifications and toolkits enabling potential integration with the VISA digital payment rail. Crunchfish’s patent pending Digital Cash solutions are built on a two-tier offline vs. online settlement architecture. As a VISA Technology Partner, Crunchfish will get access to VISA specifications and toolkits enabling Digital Cash development, evaluation and potential integration with the VISA

INITIATOR PHARMA: YEAR END REPORT 2020

Financial Highlights Initiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Fourth Quarter (2020-10-01 – 2020-12-31) · Net revenues were TDKK 0 (0) · Operating loss, EBIT was TDKK -2,069 (-2,503) · Earnings per share was DKK –0.01 (-0.06) Full Year (2020-01-01 – 2020-12-31) · Net revenues were TDKK 0 (0) · Operating loss, EBIT was TDKK -10,531 (-9,339) · Earnings per share was DKK –0.32 (-0.34) · Cash and bank: TDKK 13,504 (7,562) · Solidity: 92% (87%) Group earnings per share:

Heliospectra AB (publ) Year End Report 2020

(Gothenburg, Sweden, February 19, 2021) – Heliospectra AB (publ) (OTCQB: HLSPY, First North Growth Market: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, presents Year End Report 2020.Summary Year End Report 2020 SALES AND FINANCIAL PERFORMANCE, OCTOBER – DECEMBER Net sales amounted to KSEK 11,296 (2,784). The operating loss amounted to KSEK -9,481 (-18,502) KSEK, signifying a negative operating margin (neg). The loss after tax was KSEK -9,485 (-18,514). Orders during the period amounted to KSEK 9,440. SALES AND

Acting CFO

As previously announced, the current CFO, Claes Engvall, will leave his position in May 2021. Recruitment for a replacement is ongoing. As of May 17, Anette Lundh will take on the role as acting CFO. She has extensive experience as CFO from industrial companies and has worked for Studsvik on a consultancy basis. For more information please contact: Camilla Hoflund, President and CEO, +46 155 22 10 66   Facts about Studsvik Studsvik offers a range of advanced technical services to the global nuclear power industry. Studsvik's business focus areas are fuel and materials

GJF: Capital Markets Day 24 November 2021 - save the date

Gjensidige Forsikring will host a virtual Capital Markets Day for investors and analysts on 24 November 2021. The event will start at 09:00 CET.  Additional details, including agenda and registration for virtual participation, will be sent out closer to the date of the event. Contact person Gjensidige Forsikring ASA: Head of Investor Relations: Mitra H. Negård. Tel: +47 957 93 631Investor Relations Officer: Kjetil G. Østvold. Tel: +47 468 63 004

Per Norén appointed new CEO at Ovzon

Inside information: Ovzon's Board of Directors has today appointed Per Norén as the CEO of Ovzon AB effective latest May 1 2021. The company’s current CEO Magnus René will continue to lead the company until then and will thereafter remain in his role as a member of the Board of Directors.Per Norén has a background from leading Swedish and US technology companies. He most recently served as President of Global Eagle, the satellite and connectivity services provider. Prior to that, he was Vice President at Boeing in Seattle and CEO at Carmen Systems. Carmen Systems was a fast-growing Swedish

Arctic Bioscience AS: NOK 300 million Private Placement successfully placed

Arctic Bioscience is pleased to announce that the Private Placement has successfully been placed.Reference is made to the announcement from Arctic Bioscience AS (“Arctic Bioscience” or the “Company”) published on 16 February 2021 regarding a contemplated Private Placement (as defined below) and admission to trading on Euronext Growth Oslo (the “Admission”). The Company is pleased to announce that the Private Placement (as defined below) has been successfully placed through the allocation of 9,677,419 new shares in the Company (the “New Shares”) at a price of NOK 31.00 per share (the “

BEWI launches updated vision, brand and website

BEWI, a leading provider of packaging, components, and insulation solutions, today launches an updated brand with a new visual identity reflecting the company’s new vision: Protecting people and goods for a better everyday. At the same time, a new website is launched and the name changes back to BEWI. “BEWI was founded as a family company in 1980. During the 40 years we have been in business, we have kept challenging and transforming what we do to be able to deliver the best and most efficient solutions to our customers. Today I am proud to release our updated brand that reflects our

Kiilto and Polish modular construction pioneer UNIHOUSE cooperate on waterproofing systems

Kiilto has been providing the Polish market with adhesives for floor coverings and floor screeds for more than twenty years. Now, Kiilto is seeing a growing popularity for its waterproofing systems for bathrooms, kitchens, laundries, saunas and terraces among its Polish customers, including UNIHOUSE SA.UNIHOUSE SA is one of the largest companies in modular construction on the European market. Presently, the company’s key market is Norway. Buildings manufactured by the Polish factory in Bielsk Podlaski can also be found in Sweden, Denmark, Germany and Poland. UNIHOUSE’s focus on ecology,

Hufvudstaden welcomes Diesel to Bibliotekstan

Italian lifestyle brand Diesel is opening a flagshipstore in one of Hufvudstaden’s premises on Biblioteksgatan 12 in Bibliotekstan, Stockholm in the autumn of 2021. The store will a surface area of approximately 180sqm.Diesel, founded in 1978 by Renzo Rosso, is an international lifestyle brand producing a wide-range collection of jeans, apparel, accessories and interiors with a strong focus and passion on denim. Over the years, Diesel has perfected the art of next level denim, centring its premise on innovative treatments, premium quality and craftsmanship. Each collection carries seasonal

Invitation to CELLINK’s earnings call – Year-end Report 2019/2020

On February 25, 08.00 (CET) CELLINK will publish the Year-end Report 2019/2020 and will also arrange an earnings call, 14:00 (CET) the same date. The earnings call will be available afterwards on the company’s website Investor section.Before the start of the conference call the earnings call presentation will be available on the company's website  Investor section. The presentation will be held in English. Date: Thursday, February 25, 2021. 14:00 (CET)For audio: +46 8 502 439 36  Conference ID: 888 731 010#For video:

Year-end report January – December 2020: Catena stands strong

Catena showed strong earnings for 2020, maintaining a stable cash flow trend and high value growth. While the Corona pandemic has entailed everyday challenges for Catena, it has also brought new business opportunities and growing interest in logistics properties.19 February 2021, 08.00 a.m. · Rental income increased by 7 percent to SEK 1,263.9 million (1,182.9). · The net operating surplus increased by 11 percent to SEK 1,003.8 million (902.8). · Profit from property management rose by 15 percent to SEK 718.6 Mkr (626.8). · Profit for the year increased to SEK 1,527.1 million (

Report for the fourth quarter 2020 and preliminary year-end accounts

Financial and operating highlights 4Q20 (4Q19 in brackets): · Operating revenues were NOK 1 574 million (NOK 1 893 million) · EBITDA was NOK 206 million (NOK 188 million) · EBIT was NOK -146 million (NOK -289 million) · Net result after tax was NOK -289 million (NOK -162 million) Post quarter event: · Dividend proposal of NOK 4.00 per share, for the Company NOK 170 million · Equity in the parent company post dividend NOK 7 007 million (NOK 7 506) Segment highlights 4Q20 (4Q19 in brackets): Renewable Energy · EBITDA NOK 247 mill. (NOK 276 mill.) ·

Caverion to carry out installations of electrical and ICT systems for Metsä Group’s new sawmill in Finland

Caverion Corporation Investor news 19 February 2021 at 9.00 a.m. EETCaverion to carry out installations of electrical and ICT systems for Metsä Group’s new sawmill in Finland Caverion has signed an agreement with Metsä Fibre, part of Metsä Group, for the installation of electrical and ICT systems in the world’s most modern sawmill under construction in Rauma, Finland. The project includes all electrical installations for the building solutions, such as electricity distribution, lighting, telecommunications, fire alarm and emergency lighting installations. “We want the best

TePe sets up a regional support office in Asia

TePe reinforces their presence in Asia and announces the establishment of an office in central Singapore in March 2021. The mission is to strengthen the TePe brand and increase health awareness in the region.Helen Richenzhagen, Global Sales Director at TePe, says, “We see tremendous potential in the Asian markets through their interest in Swedish quality, innovation and sustainability. Our tactical decision to establish a regional support office in Singapore will enable intensified collaboration with our distributors, focused on educational efforts and growing our brand.”  Business

Prostatype Genomics presents Quarterly- & Year End Report

Prostatype Genomics AB has today published its quarterly report for the sixth quarter of the extended financial year comprising the period from 1 October 2020 to 31 December 2020, and the year end report for the extended financial year. The extended financial year covers the period from 1 July 2019 to 31 December 2020. The report is available on the company website.Quarter 6* (1 October – 31 December 2020) summarized · Net sales amounted to 347 (10) TSEK. · EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to -4 731 (-1 831) TSEK. · Cash flow from

Financial statement bulletin for 1 January – 31 December 2020 (unaudited)

Loudspring Oyj Company release 19 February 2021 at 9:00 (EET) The full financial statement bulletin 2021 report in PDF can be found here.  LOUDSPRING IN BRIEF We manage a portfolio of Nordic growth companies that are making a big environmental impact globally. We believe that as our entrepreneurial teams are contributing to solving some of the biggest challenges our planet faces, this translates into a unique opportunity for growing profitable businesses. Loudspring is an

Year-end report

January 1 – December 31, 2020The fourth quarter in figures · Net sales amounted to TSEK 3,055 (2,800). · The loss after tax amounted to TSEK 9,839 (10,207). · The loss per share amounted to SEK 0.20 (0.61). · The cash flow from current operations was negative in the amount of TSEK 10,290 (8,842). · The gross margin reached 49.4% (58.0%). · Electrode sales volume increased by 4% and reached 7,492 (7,180) units. Repeat sales of electrodes to existing customers increased by 6%. The full year in figures · Net sales amounted to TSEK 9,521 (9,276). · The loss after

Inzile AB (publ) Year-end Report January 1 - December 31, 2020

Fourth quarter 2020 in brief · Cooperation agreement with Eways was signed · Framework agreement with Doorier was concluded · Supplementary order was delivered to Bring · Orders were received from Tier Mobility for 10 electric trucks · Carnegie Investment Bank was engaged as financial advisor Fourth quarter in numbers · Net sales amounted to SEK 2.1 (0) million · Operating profit (EBIT) amounted to SEK -24.3 (-35.6) million · Result for the period amounted to SEK -24.4 (-35.6) million · Earnings per share before and after dilution amounted to SEK -1.42 (-2.

Episealer® Patellofemoral System - planned 510(k) submission in Q4 2021

Episurf Medical (Nasdaq: EPIS B) today announces that the company intends to submit a 510(k) application to the US FDA regarding a two-component patellofemoral implant system, the Episealer® Patellofemoral System, during 2021. The company’s aim is to launch the product on the US market in 2022. Patellar cartilage lesions are common and often occur in conjunction with lesions on the femoral knee joint. Episurf Medical has therefore initiated a development project to use the company’s imaging and CAD technology for a two-component system consisting of one implant for the trochlear area in

There are no items matching the current filter
There are no more items matching the current filter
Back to top